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ABSTRAK
Latar belakang: infeksi human immunodeficiency virus (HIV) dan acquired immune deficiency syndrome 
(AIDS) merupakan masalah kesehatan masyarakat yang sangat serius dan mempengaruhi perekonomian di 
Indonesia. Provinsi Papua memiliki prevalensi HIV tertinggi di negeri ini. Namun data tentang epidemiologi 
HIV sangat terbatas. Oleh karena itu, dilakukan studi sero-epidemiologi HIV pada orang sehat yang berada di 
daerah Paniai, Papua. Metode: pemeriksaan serologi dilakukan pada 157 orang sehat dari populasi umum di 
Paniai, Papua. Selain itu, studi epidemiologi molekuler kemuian dilakukan pada gen HIV tipe 1 (HIV-1) dari 
individu yang ditemukan terinfeksi. Analisis genotipe dilakukan terhadap sampel darah perifer dari individu 
HIV-1-positif dan 15 sampel tambahan dari individu yang sebelumnya telah dikonfirmasi positif HIV-1. Hasil: 
pemeriksaan  serologis menunjukkan bahwa 2 dari 157 orang sehat (1,27%) dinyatakan positif HIV. Pemeriksaan 
genotip pada sampel HIV-1 menunjukkan bahwa subtipe B dan circulating recombinant form (CRF) CRF01_AE 
merupakan subtipe terbanyak dan CRF HIV-1 yang banyak ditemukan di wilayah tersebut, sementara subtipe A1 
dan rekombinan antara CRF01_AE dan subtipe B juga ditemukan pada penelitian ini. Selain itu, pada pasien 
HIV yang sudah mendapatkan terapi ARV juga ditemukan mutasi mayor pada daerah reverse transcriptase. 
Kesimpulan: hasil penelitian ini dapat memberikan informasi penting untuk memahami situasi perkembangan 
HIV/AIDS saat ini di provinsi Papua di Indonesia.
Kata kunci: HIV-1, Papua, subtipe B, CRF01_AE, resistensi obat HIV.
ABSTRACT
Background: human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome 
(AIDS) cause serious health problems and affect the Indonesian economy. Papua province has the highest 
prevalence of HIV infection in the country; however, epidemiological data are limited. Therefore, in order to 
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reveal the current situation of HIV/AIDS in Papua province, sero- and molecular epidemiological studies of 
HIV were conducted. Methods: serological tests were conducted on 157 healthy individuals from the general 
population residing in Paniai, Papua. In addition, a molecular epidemiological study was then conducted on 
HIV type 1 (HIV-1) genes derived from infected individuals. Peripheral blood samples from HIV-1-positive 
individuals and 15 additionally enrolled, previously confirmed HIV-1-positive individuals were subjected to 
a genotypic analysis. Results: serological tests revealed that 2 out of 157 (1.27%) healthy individuals were 
HIV-positive. In addition, HIV-1 subtyping revealed that subtype B and CRF01_AE were the major subtype and 
circulating recombinant form (CRF) of HIV-1 prevalent in the region, while subtype A1 and a recombinant form 
including viral gene fragments of CRF01_AE and subtype B was also detected. In addition, HIV drug resistance-
associated major mutations were detected in the reverse transcriptase gene derived from infected individual on 
antiretroviral therapy. Conclusion: these results provide important information for clearer understanding on 
the current situation of HIV/AIDS in Papua province in Indonesia.
Keywords: HIV-1, Papua, subtype B, CRF01_AE, HIV drug resistance.
INTRODUCTION
Human immunodeficiency virus (HIV) is the 
causative agent of acquired immunodeficiency 
syndrome (AIDS). Although the number 
of new cases of HIV continues to decrease 
worldwide each year, the epidemic growth of 
HIV is continuing in several countries.1 In Asia 
and the Pacific region, the annual incidence 
of HIV infection has decreased in many 
countries, including India, Myanmar, Thailand, 
Vietnam and Papua New Guinea; however it 
has continuously and markedly increased in 
Indonesia, particularly since 2000.1,2 In 2013, 
there were 640,000 individuals with HIV type 
1 (HIV-1) in Indonesia,1,2 while the annual 
number of new cases of HIV in Indonesia was 
75,000, accounting for 23% of all cases among 
countries in Asia and the Pacific region, second 
to India (38%).1 Hence, HIV/AIDS remains 
a significant public health issue in Indonesia 
and has a negative impact on its economy. The 
largest number of individuals with HIV-1 is in 
Jakarta, the capital city of Indonesia, while the 
highest prevalence has been reported in Papua 
province.3 The major route of HIV-1 infection 
is considered to be through heterosexual 
transmission in Papua, and key HIV-affected 
populations are aged between 15 and 49 years 
old. In addition, the prevalence of HIV among 
the ethnic Papuan population is almost 2-fold 
of that among non-ethnic Papuans (2.8% versus 
1.5%).4 Nevertheless, epidemiological data on 
HIV-1 in Indonesia, particularly in rural areas 
such as Papua province, are limited.
HIV-1 is characterized by extensive genetic 
heterogeneity and has been divided into four 
groups: M (major), O (outlying), N (new or 
non-M, non-O) and P (pending). Group M viruses 
are further classified into a number of subtypes 
and circulating recombinant forms (CRFs). 
Of these, subtypes A, B, C, D and G, as well 
as CRF01_AE and CRF02_AG, are the major 
subtypes and CRFs responsible for the worldwide 
HIV-1 pandemic.5 While subtype B of HIV-1 is 
the predominant subtype in the Americas, Europe 
and Australia, there is a growing epidemic of 
non-B subtypes and CRFs in Africa and Asia. 
CRF01_AE is prevalent throughout Southeast 
Asia5 and is responsible for more than 90% of 
infected cases in Indonesia.6 In addition, several 
recombinant forms between CRF01_AE and 
subtype B, including CRF33_01B, have emerged 
in Indonesia.6-9 Different subtypes and CRFs 
are considered to show different rates of disease 
progression, immune responses, responses 
to antiretroviral therapy (ART), and/or the 
development of drug resistance.10 Therefore, it 
is important to monitor the global prevalence of 
subtypes and CRFs for HIV-1 prevention and 
control as well as for vaccine development.
In order to clarify the prevalence of HIV-
1 in Papua province in Indonesia, a sero-
epidemiological study of HIV-1 among 157 
healthy individuals was conducted in Paniai, 
Papua. In addition, a molecular epidemiological 
study on the viral genomes derived from 17 
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HIV-1-infected individuals was also performed 
in order to identify currently circulating HIV-1 
subtypes and CRFs in Papua.
METHODS
This study was conducted with approval 
from the Institutional Ethics Committees of the 
Institute of Tropical Disease and the Institute 
for Research and Public Service, Universitas 
Airlangga on September 2nd, 2013 with a 
reference number of 25-995/UN3.14/PPd/2013 
and Kobe University Graduate School of 
Medicine on September 20th, 2012, as well 
as with written informed consent from study 
participants.
Study Participants and Sample Collection
In this study, we collected two sets of blood 
samples. The first set were collected from 
blood samples from general population for the 
sero-epidemiological study of HIV-1, while 
the second set were collected samples from 
HIV-1-infected individuals for the molecular 
epidemiological study of HIV-1 (Figure 1). 
In the sero-epidemiological study of HIV-1, 
157 healthy individuals were enrolled from 
the general population with assistance from 
the Enarotali Public Health Center and the 
General Hospital of Paniai in August 2014. 
The samples from general population were 
obtained randomly from some patients who 
had previously diagnosed with viral hepatitis or 
some general patients coming to the Enarotali 
Public Health Center and the General Hospital of 
Paniai. Fifteen individuals previously diagnosed 
with HIV-1 seropositive were additionally 
enrolled at the General Hospital of Paniai for 
the molecular epidemiological study of HIV-1. 
Most participants were from indigenous tribes 
of Papua, while 12 participants were from 
other provinces in Indonesia. The personal 
information of study participants, including 
age and gender as well as the statuses of the 
Hepatitis B surface antigen (HBs Ag), anti-
HCV antibody and ART were collected by a 
questionnaire or from medical records. Ten 
milliliters of ethylenediaminetetraacetic acid 
(EDTA) anti-coagulated peripheral blood was 
collected from each participant. Plasma was 
then isolated from peripheral blood samples 
by centrifugation at 2,000 rpm for 10 min. In 
addition, peripheral blood mononuclear cells 
(PBMC) were isolated by density gradient 
centrifugation using Histopaque 1077 (Sigma-
Aldrich, St. Louis, MO, USA). RNA and DNA 
were then extracted from plasma and PBMC 
using the QIAamp Viral RNA Mini kit (Qiagen, 
Hilden, Germany) and GenElute Mammalian 
Genomic DNA Miniprep kit (Sigma-Aldrich), 
respectively.
Sero-epidemiology
Plasma samples were tested for anti-HIV 
antibodies using a commercially available 
rapid diagnostic kit [ABON HIV 1/2/O Triline 
Human Immunodeficiency Virus Rapid Test 
Devices; Abon Biopharm (Hangzhou) Co., Ltd., 
Hangzhou, China]. If the results of the rapid 
diagnostic kit were positive, HIV-1 genomic 
fragments were amplified by a polymerase chain 
reaction (PCR) to confirm the diagnosis of HIV-1 
infection.
Amplification of HIV-1 Genomic Fragments
RNA and DNA were extracted from plasma 
and PBMC isolated from HIV-1-positive samples. 
Viral RNA in plasma RNA samples was reverse 
transcribed to cDNA using the SuperScript III 
First-Stand Synthesis kit (Invitrogen, Carlsbad, 
CA, USA) with the reverse primer, K-env-R1, 
5’-CCAATCAGGGAAGAAGCCTTG-3’ 
[corresponding to nucleotides (nt) 9168 to 9148 
of the HIV-1 reference strain, HXB2 (GenBank 
accession no. K03455)]. The viral pol genes 
encoding protease (PR) (PR gene) and reverse 
transcriptase (RT) (RT gene) as well as partial 
fragments of the gag and env genes were then 
amplified from cDNA by a nested polymerase 
chain reaction (PCR) using Ex Taq polymerase 
(Takara Bio, Shiga, Japan) and the following 
primers. In the amplification of the PR gene, 
the primers for first PCR were DRPR05, 
5’-AGACAGGYTAATTTTTTAGGGA-3’ 
( n t  2 0 7 4  t o  2 0 9 5 )  a n d  D R P R 0 2 L , 
5’-TATGGATTTTCAGGCCCAATTTTTGA-3’ 
(nt  2716 to 2691),  while the primers 
f o r  n e s t e d  P C R  w e r e  D R P R 0 1 M , 
5’ -AGAGCCAACAGCCCCACCAG-3’ 
( n t  2 1 4 8  t o  2 1 6 7 )  a n d  D R P R 0 6 , 
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5’-ACTTTTGGGCCATCCATTCC-3’ (nt 
2611 to 2592). In the amplification of the RT 
gene, the primers for first PCR were RT1L, 
5’-ATGATAGGGGGAATTGGAGGTTT-3’ (nt 
2388 to 2410) and GPR2M, 5’-GGACTACAGTCY 
ACTTGTCCATG-3’ (nt 4402 to 4380), while 
the primers for nested PCR were RT7L, 
5’-GACCTACACCTGTCAACATAATTGG-3’ 
(n t  2485  to  2509)  and  GPR3L,  5 ’ - 
TTAAAATCACTARCCATTGYTCTCC-3’ 
(nt 4309 to 4285). In the amplification of the 
gag gene encoding Gag p24, the primers for 
first PCR were H1G777, 5’- TCACCTAGAAC 
TTTGAATGCATGGG-3’ (nt 1231 to 1255) and 
H1P202, 5’-CTAATACTGTATCATCTGCT 
GCTCCTGT-3’ (nt 2352 to 2325), while the 
primers for nested PCR were H1Gag1584, 
5’-AAAGATGGATAATCCTGGG-3’ (nt 
1577 to 1595) and G17, 5’-TCCACATTTC 
CAACAGCCCTTTTT-3’ (n t  2040  to 
2017). In the amplification of the C2-V3 
regions of the env gene, the primers for 
first PCR were M5,-CCAATTCCCATACAT 
TATTGTGCCCCAGCTGG-3’ (nt  6858 
to 6889) and M10, 5’-CCAATTGTCCCT 
CATATCTCCTCCTCCAGG-3’ (nt 7661 
to 7632), while the primers for nested 
PCR were M3, 5’-GTCAGCACAGTAC 
A AT G I A C A C AT G G - 3 ’ ( n t  6 9 4 8  t o 
6973) and M8, 5’-TCCTTCCATGGGA 
GGGGCATACATTGC-3’ (nt 7547 to 7521). 
PCR conditions are available upon request. If a 
viral gene fragment failed to be amplified from 
cDNA generated from plasma RNA samples even 
after multiple attempts, it was amplified instead 
from DNA extracted from PBMC samples. 
In order to examine the genomic fragment of 
the major viral population in a sample, PCR 
products amplified at the end-point dilution of 
DNA templates were subjected to a sequencing 
analysis.
Sequencing Analysis, HIV-1 Subtyping and 
the Detection of Drug Resistance-associated 
Mutations
A sequencing analysis of the amplified HIV-
1 genomic fragment was performed using the 
BigDye Terminator v3.1 Cycle Sequencing kit 
with an ABI PRISM 3500 xl genetic analyzer 
(Applied Biosystems, Foster City, CA, USA). 
Sequencing data were then assembled and 
aligned using Genetyx version 10 software 
(Genetyx, Tokyo, Japan). HIV-1 subtyping was 
performed using the recombinant identification 
program (RIP), which is available on the website 
of the HIV sequence database (www.hiv.lanl.
gov/). In addition, neighbor-joining (NJ) trees 
with a Kimura two-parameter model were 
constructed using MEGA6.06 software11 with 
HIV-1-infected
individuals coming to the
general hospital of Paniai
(n=15)
Patients previously
diagnosed to be viral
hepatitis (n=21) or
general patients (n=136)
coming to the Enarotali
public health center
(n=115) or at the general
hospital of Paniai
(n= 42)Informed consent
Amplification of HIV-1
genomic fragments
blood withdrawal
HIV serogical test
Positive
(n=2)
HIV-1 Subtyping
Negative
(n=155)
Analysis of ART drug
resistance
Figure 1. Flow chart of the sample collection and experimental plans
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bootstrap values (1,000 replicates) for relevant 
nodes being reported on a representative tree. 
Viral subtyping was performed based on the 
successfully sequenced PR, RT, gag and/or 
env genes, and if there was an incompatibility 
in the subtype or CRF among the genes, 
the viral gene was considered to be from a 
recombinant form of HIV-1. In addition, the 
determination of drug resistance mutations in 
RT genes derived from individuals on ART 
was based on the guidelines published by 
the International AIDS Society United States 
(IAS-USA).12 The nucleotide sequences of 
viral gene fragments have been deposited in the 
GenBank database under accession numbers 
KX639349-KX639352, KX639354-KX639358, 
KX639360-KX639368, KX639370-KX639387 
and KX639389-KX639399.
RESULTS
Sero-epidemiological Study of HIV-1 in Papua 
Province
One hundred and fifty seven peripheral 
blood samples were corrected from the general 
population of Papua province in Indonesia. 
Forty-two and 115 samples were collected at 
the general hospital of Paniai and the Enarotali 
public health center, respectively (Figure 1). 
Serological tests revealed that 2 out of 157 
samples (1.27%) were positive for anti-HIV 
antibodies. Two HIV-1-infected individuals were 
a 16-year-old male and a 36-year-old female, 
who were both married.
Demographic Information on Study 
Participants
In addition to 157 study participants, 
including 2 HIV-1-infected individuals, from 
the general population, 15 HIV-1-infected 
individuals were enrolled from the general 
hospital of Paniai for the genotypic analysis of 
HIV-1 (Figure 1). The demographic information 
of all study participants, consisting of 17 HIV-1-
infected and 155 HIV-1-uninfected individuals, 
is shown in Table 1. Ten out of 17 (58.8%) 
HIV-1-infected individuals were female, and 
3 out of 17 (17.6%) were HBs Ag-positive, 
indicating the co-infection of hepatitis B virus 
(HBV) and HIV-1. In contrast, none of the 
HIV-1-infected individuals were positive for the 
anti-hepatitis C virus (HCV) antibody, indicating 
no co-infection of HCV and HIV-1 among HIV-
1-infected study participants. No significant 
differences were observed in the infection rates 
of HBV and HCV between HIV-1-infected and 
-uninfected individuals. The mean age of HIV-
infected individuals was 25 years old, with the 
most predominant age groups being 20-29 and 
30-39 years old. Fifteen out of 17 (88.2%) HIV-
1-infected individuals were married (Table 1).
Table 1. Demographic information on HIV-positive and 
-negative study participants
HIV (+) HIV (-)
Gender (n)
 - Female 10 108
 - Male 7 47
HBs Ag, n (%)
 - (+) 3 (17.64) 19 (12.25)
 - (-) 14 (82.35) 136 (87.74)
Anti-HCV, n (%)
 - (+) 0 (0.0) 2 (129)
 - (-) 17 (100.0) 153 (98.7)
Age (n)
 - <20 years 5 17
 - 20-29 years 6 92
 - 30-39 years 6 37
 - ≥40 years 0 9
Marriage status (n)
 - Married 15 NA
 - Unmarried 2 NA 
HIV-1 Subtyping
Viral subtyping was performed using a 
phylogenetic tree analysis of successfully 
sequenced PR, RT, gag and env gene fragments 
(Figure 2). The results obtained showed that 8 out 
of 16 samples (50%) were classified as subtype 
B, six (37.5%) were classified as CRF01_AE, 
one sample (6.25%) was classified as subtype 
A1, and one sample (6.25%) was a recombinant 
form containing CRF01_AE and subtype B 
(CRF01_AE/B) genomic fragments (Table 2). 
In contrast, HIV-1 genomic fragments failed to 
be amplified from the sample, HIP 1 (Table 2). 
Viral subtyping was also performed using RIP, 
and the results obtained were consistent with that 
by a phylogenetic tree analysis (data not shown).
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Figure 2. Phylogenetic analysis of HIV-1 PR, RT, gag and env gene sequences. Phylogenetic trees were generated for the 
newly sequenced HIV-1 PR (A), RT (B), gag (C) and env genes (D) together with the corresponding viral genes of reference 
HIV-1 strains representing subtype A1 (A1), subtype A2 (A2), subtype B (B), subtype C (C), subtype D (D), subtype G (G), 
CRF01_AE (01_AE), CRF02_AG (02_AG), CRF15_01B (15_01B), CRF33_01B (33_01B) and CRF34_01B (34_01B). The 
reference strains of the HIV-1 subtype are shown in bold. Sequence codes are presented as the GenBank accession number, 
patient ID or name of the reference strain, and the subtype or CRF of the reference strain (shown in parentheses) in order. 
Bootstrap values were shown when values were >70. CRF, circulating recombinant form.
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HIV Drug Resistance-associated Mutations
Among 17 HIV-1-infected individuals, 
eight (47.1%) were on ART using RT inhibitors; 
therefore, the appearance of drug resistance-
associated mutations was evaluated on RT genes 
derived from the samples of these individuals. 
The results obtained showed that three drug 
resistance-associated major mutations, K103N 
[amino acid substitution from lysine (K) to 
asparagine (N) at position 103 in RT], M184V 
and T215F, were detected in the viral RT gene 
derived from HIP 7. This patient used lamivudine 
(3TC), efavirenz (EFV) and tenofovir disoproxil 
fumarate (TDF) (Table 3). These drug resistance-
associated major mutations were not detected 
in the other two patients who use same drug 
combinations (HIP 14 and HIP 16). No drug 
resistance-associated mutations were detected in 
the five remaining samples who used zidovudine 
(AZT), 3TC and nevirapine (NVP), or AZT, 
3TC and EFV. In addition, no drug resistance-
associated mutations were detected in patients 
who were not on ART.
In protease gene, no drug resistance-
associated major mutations were detected (data 
not shown).
DISCUSSION
HIV/AIDS was initially detected in Indonesia 
in 1994. Since then, the epidemic has been 
steadily growing. The prevalence of HIV 
infection in Papua province (2.3%) is more than 
5-fold among the general population in Indonesia 
(0.4%).14 In addition, sexual behavior among the 
people of Papua was reported to increase the 
risk of HIV infection.4 The HIV/AIDS situation 
in Papua province had been summarized in 
20064; however, recent information is limited. 
Two out of 157 healthy individuals from the 
general population were found to be infected 
with HIV-1. The prevalence of HIV was 1.27% 
in the present study, while it was previously 
reported to be 2.3%,13 suggesting a decrease in 
its prevalence in the region. It is conceivable that 
large scale surveillance might be necessary for 
revealing the current prevalence of HIV in this 
region; however, difficulties are associated with 
conducting international collaborative studies 
there.
Demographic data on HIV-1-infected 
Table 2. HIV-1 subtyping
Sample ID subtype/CRF assignment
subtyping
RT gene PR gene env gene gag gene
HIP 1 NA* NA NA NA NA
HIP 2 CRF01_AE NA NA CRF01_AE NA
HIP 3 CRF01_AE CRF01_AE CRF01_AE CRF01_AE CRF01_AE
HIP 4 B B B NA NA
HIP 5 B B B B B
HIP 6 CRF01_AE CRF01_AE CRF01_AE CRF01_AE CRF01_AE
HIP 7 B B B NA B
HIP 8 CRF01_AE CRF01_AE CRF01_AE CRF01_AE CRF01_AE
HIP 9 B B B B NA
HIP 10 CRF01_AE CRF01_AE CRF01_AE CRF01_AE CRF01_AE
HIP 11 B B B B B
HIP 13 B B B B B
HIP 14 CRF01_AE CRF01_AE CRF01_AE NA CRF01_AE
HIP 15 CRF01_AE/B** CRF01_AE NA B NA
HIP 16 B B NA B B
PPC10 A1 NA NA A1 NA
HPB 5 B NA NA B NA
* Not available due to the failure of PCR.
**recombinant form of HIV-1 containing viral gene fragments of CRF01_AE and subtype B.
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Table 3. Clinical information of 17 HIV-infected individuals
ID Anti-retroviral Treatment
Duration of 
HIV infection 
(month)
Types of ART HBs Ag Anti-HCV
Drug Resistance-
associated 
Mutation in RT
HIP1 Yes 64 AZT + 3TC + NVP - - -
HIP2 Yes 23 AZT + 3TC + NVP - - -
HIP3 Yes 33 AZT + 3TC + NVP - - -
HIP4 No 1 + - -
HIP5 No 0 - - -
HIP6 No 0 - - -
HIP7 Yes 34 3TC + EFV + TDF - - K103N, M184V, T215F
HIP8 No 0 - - -
HIP9 No 0 - - -
HIP10 Yes 137 AZT + 3TC + EFV - - -
HIP11 No 0 - - -
HIP13 No 0 + - -
HIP14 Yes 30 3TC + EFV + TDF - - -
HIP15 Yes 31 AZT + 3TC +EFV - - -
HIP16 Yes 5 3TC + EFV + TDF + - -
PPC10 No 0 - - -
HBP5 No 0 - -  -
Note: ART, antiretroviral therapy; 3TC, lamivudine; AZT, zidovudine; NVP, nevirapine; EFV, efavirenz; TDF, tenofavir
individuals showed that 15 out of 17 individuals 
(88.2%) were married. Consistent with the 
results of the present study, previous findings 
obtained in Jayapura, the provincial capital of 
Papua, showed that a large proportion of HIV-
positive individuals were married (literature in 
Indonesian language). A significant proportion 
of men who have sex with men were married to 
women.1,14 In addition, 25-60% of male injection 
drug users in Asia were either married or have 
an intimate partner.14 Women are known to be at 
high risk of HIV infection from their husbands 
or intimate partners.1 Therefore, it is important to 
conduct surveillance to reveal the conditions for 
HIV transmission between infected individuals 
and their partners in Papua province.
HIV-1 subtyping revealed that subtype B 
and CRF01_AE were the major subtype and 
CRF prevalent in Papua province in Indonesia. 
In addition, subtype A1 and a recombinant form 
containing CRF01_AE and subtype B were 
detected as minor strains. CRF01_AE is the 
predominant strain of HIV-1 in Southeast Asia5. 
It is also the predominant strain of HIV-1 in 
Indonesian cities such as Jakarta and Surabaya, 
while the CRF01_AE and subtype B recombinant 
forms have also been detected as minor strains 
in these regions.6-9 In contrast, CRF01_AE and 
subtype B were prevalent as major strains in West 
Papua.15,16 Consistent with the reports, subtype B 
and CRF01_AE were prevalent in Paniai, Papua 
as major strains. Since an unusual subtype in 
Southeast Asia, subtype A1 was also detected 
in this study, more complex recombinant forms 
and new CRFs might possibly be generated in 
the region in the future. Therefore, it is important 
to continue monitoring HIV-1 subtypes in 
Papua province. In addition, 3 drug resistance-
associated major mutations, K103N, M184V and 
T215F, were detected from the RT gene derived 
from a patient, HIP 7. These are commonly 
occurring mutations against non-nucleoside 
reverse transcriptase inhibitors (NNRTIs) or 
nucleoside/nucleotide reverse transcriptase 
inhibitors (NRTIs). The patient had been on 
ART with a fixed-dose combination of TDF, 
3TC and EFV. Same drug resistance-associated 
major mutations are also detected from a patient 
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who uses other first-line ART in Surabaya, 
Indonesia.17 The appearance of drug resistance 
mutations against the first regime of ART as 
well as transmitted drug resistance need to be 
monitored in Papua province.
CONCLUSION
The current prevalence of HIV among the 
general population in Paniai, Papua is 1.27%, 
which is lower than that reported for Papua 
province in 2006. In addition, subtype B and 
CRF01_AE viruses were prevalent as major 
subtype and CRF in the region. Moreover, three 
drug resistance-associated major mutations were 
detected in one out of six samples. The limitation 
of this study is its low sample size, and intensified 
sero- and molecular epidemiological studies may 
be required in order to reveal the current situation 
of HIV infection in Papua province in Indonesia.
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